Disclosures for "Utility of the Inpatient Movement Neurophysiology Study in the Management of Refractory Dyskinesias Due to Anti-NMDA Receptor Encephalitis"
-
Dr. Sherfinski has nothing to disclose.
-
Dr. Grill has nothing to disclose.
-
Dr. Knox has nothing to disclose.
-
Dr. Caviness has nothing to disclose.
-
Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.